Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Marta Korbonits"'
Autor:
Sergio Pedraza‐Arevalo, Alejandro Ibáñez‐Costa, Ricardo Blázquez‐Encinas, Miguel R. Branco, Mari C. Vázquez‐Borrego, Aura D. Herrera‐Martínez, Eva Venegas‐Moreno, Raquel Serrano‐Blanch, Álvaro Arjona‐Sánchez, María A. Gálvez‐Moreno, Marta Korbonits, Alfonso Soto‐Moreno, Manuel D. Gahete, Marika Charalambous, Raúl M. Luque, Justo P. Castaño
Publikováno v:
Molecular Oncology, Vol 16, Iss 3, Pp 764-779 (2022)
Somatostatin receptor subtype 5 (SST5) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors. Transcriptional and epigenetic regulation of SSTR5 gene expression and mRNA biogenesis is poo
Externí odkaz:
https://doaj.org/article/b32f6c1bca5844c5a89dc0ab9f39ab12
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
We observed a novel therapeutic response with cabergoline in a male patient with a dopamine-secreting head and neck paraganglioma (HNPGL), macroprolactinoma and germline succinate dehydrogenase C mutation (SDHC). The macroprolactinoma was treated wit
Externí odkaz:
https://doaj.org/article/5fb4ba49aacb4266bd524be81da88132
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2020)
The coincidence of a pheochromocytoma or paraganglioma and a pituitary adenoma in the same patient is a rare condition. In the last few years SDHx and MAX mutations have been identified and discussed as a potential causal connection in cases of coinc
Externí odkaz:
https://doaj.org/article/afb9b141bdf640c1bdbc27361cd387d4
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25201 (2011)
XAP2 (also known as aryl hydrocarbon receptor interacting protein, AIP) is originally identified as a negative regulator of the hepatitis B virus X-associated protein. Recent studies have expanded the range of XAP2 client proteins to include the nucl
Externí odkaz:
https://doaj.org/article/dc3aa8fedcc3438d8251f30b294775c3
Autor:
Lim, Chung Thong, Korbonits, Márta Korbonits *
Publikováno v:
In Endocrine Practice May 2018 24(5):473-488
Autor:
Marta Korbonits
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Autor:
Uta Neumann, Annelieke van der Linde, Ruth E Krone, Nils P Krone, Ayla Güven, Tülay Güran, Heba Elsedfy, Sukran Poyrazoglu, Feyza Darendeliler, Tania A S S Bachega, Antonio Balsamo, Sabine E Hannema, Niels Birkebaek, Ana Vieites, Ajay Thankamony, Martine Cools, Tatjana Milenkovic, Walter Bonfig, Eduardo Correa Costa, Navoda Atapattu, Liat de Vries, Guilherme Guaragna-Filho, Marta Korbonits, Klaus Mohnike, Jillian Bryce, S Faisal Ahmed, Bernard Voet, Oliver Blankenstein, Hedi L Claahsen-van der Grinten
Publikováno v:
Neumann, U, van der Linde, A, Krone, R E, Krone, N P, Güven, A, Güran, T, Elsedfy, H, Poyrazoglu, S, Darendeliler, F, Bachega, T A, Balsamo, A, Hannema, S E, Birkebæk, N, Vieites, A, Thankamony, A, Cools, M, Milenkovic, T, Bonfig, W, Costa, E C, Atapattu, N, de Vries, L, Guaragna-Filho, G, Korbonits, M, Mohnike, K, Bryce, J, Ahmed, S F, Voet, B, Blankenstein, O & Claahsen-van der Grinten, H L 2022, ' Treatment of congenital adrenal hyperplasia in children aged 0-3 years : A retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure ', European Journal of Endocrinology, vol. 187, no. 2, pp. 587-596 . https://doi.org/10.1530/EJE-21-1085
European Journal of Endocrinology, 187(2), 587-596. BioScientifica Ltd.
Neumann, U, van der Linde, A, Krone, R E, Krone, N P, Güven, A, Güran, T, Elsedfy, H, Poyrazoglu, S, Darendeliler, F, Bachega, T A S S, Balsamo, A, Hannema, S E, Birkebaek, N, Vieites, A, Thankamony, A, Cools, M, Milenkovic, T, Bonfig, W, Costa, E C, Atapattu, N, de Vries, L, Guaragna-Filho, G, Korbonits, M, Mohnike, K, Bryce, J, Ahmed, S F, Voet, B, Blankenstein, O & Claahsen-van der Grinten, H L 2022, ' Treatment of congenital adrenal hyperplasia in children aged 0-3 years : a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure ', European Journal of Endocrinology, vol. 186, no. 5, pp. 587-596 . https://doi.org/10.1530/EJE-21-1085
EUROPEAN JOURNAL OF ENDOCRINOLOGY
European Journal of Endocrinology, 186(5), 587-596. Bioscientifica Ltd
European Journal of Endocrinology, 186, 587-596
European Journal of Endocrinology, 186, 5, pp. 587-596
European Journal of Endocrinology, 187(2), 587-596. BioScientifica Ltd.
Neumann, U, van der Linde, A, Krone, R E, Krone, N P, Güven, A, Güran, T, Elsedfy, H, Poyrazoglu, S, Darendeliler, F, Bachega, T A S S, Balsamo, A, Hannema, S E, Birkebaek, N, Vieites, A, Thankamony, A, Cools, M, Milenkovic, T, Bonfig, W, Costa, E C, Atapattu, N, de Vries, L, Guaragna-Filho, G, Korbonits, M, Mohnike, K, Bryce, J, Ahmed, S F, Voet, B, Blankenstein, O & Claahsen-van der Grinten, H L 2022, ' Treatment of congenital adrenal hyperplasia in children aged 0-3 years : a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure ', European Journal of Endocrinology, vol. 186, no. 5, pp. 587-596 . https://doi.org/10.1530/EJE-21-1085
EUROPEAN JOURNAL OF ENDOCRINOLOGY
European Journal of Endocrinology, 186(5), 587-596. Bioscientifica Ltd
European Journal of Endocrinology, 186, 587-596
European Journal of Endocrinology, 186, 5, pp. 587-596
Objectives International guidelines recommend additional salt supplementation during infancy in classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The influence of corticoid medication and growth has not been assessed. Aim
Autor:
Read Jordan E, Canton Ana Pinheiro-Machado, Flavia Tinano, Leonardo Guasti, Montenegro Luciana Ribeiro, Fiona Ryan, Deborah Shears, Alyssa Paganoni, Marta Korbonits, Alexander Jorge, Alessia David, Mendonca Berenice Bilharinho, Brito Vinicius Nahime, Latronico Ana Claudia, Sasha R Howard
Publikováno v:
Endocrine Abstracts.